Lataa...
Histone deacetylase 3 controls a transcriptional network required for B cell maturation
Histone deacetylase 3 (Hdac3) is a target of the FDA approved HDAC inhibitors, which are used for the treatment of lymphoid malignancies. Here, we used Cd19-Cre to conditionally delete Hdac3 to define its role in germinal center B cells, which represent the cell of origin for many B cell malignancie...
Tallennettuna:
| Julkaisussa: | Nucleic Acids Res |
|---|---|
| Päätekijät: | , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Oxford University Press
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6847391/ https://ncbi.nlm.nih.gov/pubmed/31586401 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/nar/gkz816 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|